We’re Hiring: Join the ECETOC Team as a Trainee!
390494

We’re Hiring: Join the ECETOC Team as a Trainee!

Are you passionate about science, regulatory toxicology, and making a real-world impact at the intersection of industry, academia, and policy? ECETOC is excited to announce that we’re looking for a...
ECETOC publishes a framework for the risk assessment of plastic additives
390456

ECETOC publishes a framework for the risk assessment of plastic additives

Part 1 sets out the fundamental elements, from problem formulation to risk characterisation.Brussels, 22 July 2026. The ECETOC Plastic Additives Task Force has published the first of two peer...
HSSD Tool

HSSD Tool

This software was developed by a consortium of partners to facilitate the uptake of novel approaches to estimate aquatic threshold concentrations (e.g. the concentration at which 5% of the species are exposed above their EC50, HC5).
The Human Exposure Assessment Tools Database (heatDB)

The Human Exposure Assessment Tools Database (heatDB)

heatdb is a public directory of exposure data sources as well as available tools for exposure
NanoApp

NanoApp

ECETOC’s NanoApp is a tool designed to define the boundaries of sets of similar nanoforms and to generate a justification for the REACH registration.
Targeted Risk Assessment (TRA)

Targeted Risk Assessment (TRA)

The Targeted Risk Assessment (TRA) estimates exposures to workers, consumers and the environment that arise during a series of events.
TRA Task Force – Worker branch

TRA Task Force – Worker branch

Why? The Worker TRA Task Force has been active since 2019, delivering projects that advance the scientific basis of the Worker Targeted Risk Assessment (TRA) tool. Its overarching objective is to e...
Immunotoxicity assessment: Addressing Challenges and Advancing Methodologies [Workshop → Task Force]​

Immunotoxicity assessment: Addressing Challenges and Advancing Methodologies [Workshop → Task Force]​

Why?Regulatory assessment of immunotoxic properties of chemicals is a complex and challenging task​ Limited regulatory guidance exists​ Lack of industry and regulatory knowledge​...
Chronic fish case studies towards an IATA

Chronic fish case studies towards an IATA

Why?Hazard and safety assessments for the pelagic compartment often rely on in vivo studies using a single fish species, raising ethical concerns and uncertainty in terms of extrapolation....
Article
04.02.1995

Polypropylene production and colorectal cancer: A review of the epidemiological evidence

Polypropylene has been produced for over 35 years and has a wide variety of applications including industrial uses, food packaging and many domestic uses. As a high-molecular-weight polymer, polypropylene is considered chemically inert with little or no physiological or toxicological effects. Nevertheless, early epidemiological studies of polypropylene production workers and carpet manufacturing employees who use polypropylene reported a significant excess of colorectal cancer. In one study, five of the seven cases were diagnosed within a five-month period, and in the other study, five cases were diagnosed within an 18-month period. Recent updates of these two study populations have found no continuation of the excess of colorectal cancer, thereby indicating that the earlier observations on these two groups reflected the chance nature of a time-space cluster. Moreover, investigations of polypropylene production workers in the United States, Germany, Australia and the United Kingdom found no association with colorectal cancer. When the results of all studies of polypropylene production workers are pooled, the summary risk ratio for colorectal cancer is 1.37 (95% confidence interval 0.83–2.11). Taken together, the epidemiological evidence and the absence of toxicological data do not support a causal association between polypropylene and colorectal cancer.

Reference

Lagast H, Tomenson J, Stringer DA. 1995.
Polypropylene production and colorectal cancer: A review of the epidemiological evidence.
Occupational Medicine 45(2):69-74
Doi: 10.1093/occmed/45.2.69


Find out more
http://dx.doi.org/10.1093/occmed/45.2.69